| The FTSE Med Index Committee approved the following changes to the FTSE Med 100 Index. The changes will be effective after the close of business on Friday, 18 November 2005 (i.e. on Monday, 21 November 2005). |
PERIODIC REVIEW OF CONSTITUENTS Additions to the FTSE Med 100 Index: | Stock Name | Sedol | Country | Rank | Investability Weight | Reason | | Delek Group | 6219640 | Israel | 28 | 20% | Auto Addition | | Given Imaging | B00V9C7 | Israel | 56 | 40% | Auto Addition | | FMS Enterprises Migun Ltd | 6347778 | Israel | 70 | 100% | Auto Addition | | Delta Holdings | 4260190 | Greece | 72 | 30% | Auto Addition | | Gek Group | 4421704 | Greece | 79 | 75% | Auto Addition | | Radware | B01BZ06 | Israel | 80 | 100% | Auto Addition | | Vision International | B01FLM2 | Cyprus | 112 | 40% | Exchange Balance Addition |
Deletions from the FTSE Med 100 Index: | Stock Name | Sedol | Country | Rank | Reason | | Matav Cable System | 6573120 | Israel | 106 | Exchange Rebalancing Deletion | | Electra (Israel) Ltd | 6298821 | Israel | 108 | Exchange Rebalancing Deletion | | Crown Hellas Can Packaging | 4420682 | Greece | 110 | Rebalancing Deletion | | Iaso | 5950779 | Greece | 114 | Rebalancing Deletion | | Delta Galil Industries | 6262020 | Israel | 118 | Rebalancing Deletion | | Electra Consumer Products | 6304096 | Israel | 119 | Rebalancing Deletion | | Muskita Aluminium Industries | 5955020 | Cyprus | 121 | Auto Deletion |
Reserve list for the FTSE Med 100 Index: With immediate effect, the following reserve list will be used in the event that one or more constituents are deleted during the period up to the next semi-annual review: | Stock Name | Sedol | Country | Rank | Investability Weight | | Africa Israel Properties | B034CL3 | Israel | 88 | 100% | | Sarantis | 7124958 | Greece | 93 | 75% | | Orckit Communications Ltd | 6573818 | Israel | 95 | 75% | | Elbisco Holding | 4420949 | Greece | 102 | 20% | | Athens Medical C.S.S | 4056612 | Greece | 103 | 40% |
Investability Weight Changes for the FTSE Med 100 Index: There are no investability weight changes for the FTSE Med 100 Index. For index related enquiries or further information about FTSE please contact: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | Tel: +1 888 747 FTSE (3873) or +1 212 641 6165 | | Client Services in Asia Pacific: | Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811 |
Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com | 